Apriglim-MV 203 Tablet SR
Marketer
Aprica Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Apriglim-MV 203 Tablet SR
Diabetam-Duo 203 Extended-Release tablets are classified as antidiabetic medications. This combination drug treats type 2 diabetes in adults by regulating blood glucose. Diabetam-Duo 203 ER should be ingested with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing risks of kidney complications, vision impairment, neuropathy, and limb loss. This medication is a component of a comprehensive diabetes management plan, encompassing a balanced diet, regular physical activity, and weight management as advised by your doctor. Lifestyle significantly influences diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Prompt glucose intake (sugary foods or juice) is essential. Alcohol consumption should be limited due to its hypoglycemic effect. Additional potential side effects include altered taste, nausea, diarrhea, abdominal pain, headache, edema, blurry vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe kidney or liver disease. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals should consult their doctor. Regular blood glucose monitoring and periodic blood tests to assess blood cell counts and liver function are recommended.
Primary Ingredients of Apriglim-MV 203 Tablet SR
There is no text provided to rephrase.
Uses of Apriglim-MV 203 Tablet SR
Managing type 2 diabetes
Major Benefits of Apriglim-MV 203 Tablet SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or breaking it. Apriglim-MV 203 Tablet SR should be administered on an empty stomach.
Common Side effects of Apriglim-MV 203 Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Apriglim-MV 203 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Apriglim-MV 203 Tablet SR. Ingest the tablet whole; do not crush, chew, or fracture it. Administer this medication on an empty stomach.
How Apriglim-MV 203 Tablet SR works:
Apriglim-MV 203 sustained-release tablets contain a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Apriglim-MV 203 Tablet SR and alcohol is inadvisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Apriglim-MV 203 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Apriglim-MV 203 tablet likely poses a risk to breastfeeding infants. Available human data indicate potential transfer to breast milk, with the possibility of adverse effects on the nursing child.
DrivingCAUTION
Driving may be impaired by excessively high or low blood sugar levels. Refrain from driving if such symptoms arise.
KidneyUNSAFE
The extended-release Apriglim-MV 203 tablet is likely unsafe for individuals with kidney impairment and its use should be avoided. Medical advice is necessary. Furthermore, this medication is contraindicated in patients experiencing severe kidney dysfunction.
LiverCAUTION
Exercise caution when prescribing Apriglim-MV 203 SR tablets to individuals with hepatic impairment; dosage modification may be necessary. Physician consultation is advised. For patients exhibiting mild to moderate liver dysfunction, initiate therapy with a reduced Apriglim-MV 203 SR tablet dosage; however, its use is contraindicated in cases of severe liver disease.
What if you forget to take Apriglim-MV 203 Tablet SR :
Should you forget a dose of Apriglim-MV 203 Tablet SR, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Apriglim-MV 203 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |






